Cohort Studyhigh evidence
OMICmAge quantifies biological age by integrating multi-omics with electronic medical records.
Nature aging·March 1, 2026·PMID 41741793
Why it mattersFor clinicians interested in biologic aging and risk stratification, this work suggests a scalable methylation-based marker that may capture multisystem disease risk better than some current aging clocks. It is potentially useful for research phenotyping and longitudinal risk assessment, but not yet a routine clinical tool.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled